These are cross-listed as Noridian Jurisdiction E LCDs. Their next public comment meeting on new LCDs is February 8, at the LAX Marriott. Noridian requires registration two weeks in advance (circa Feb 24).
At the Noridian Jurisdiction E website, here, click Policies, and then Open Public Meeting (should be here).
Agenda after the break.
Listing of Draft LCDs here.
LCDs for comment below. It looks like the public comment deadlines will be 4/10/2017.
- Cataract Surgery in Adults
- Coenzyme Q10 (CoQ10) [as a blood test, for nutritional/medical supplements; not covered]
- MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Advanced Primary Peritoneal, Fallopian Tube and Ovarian Cancer
- MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Metastatic Colorectal Cancer
- MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Metastatic Melanoma
- MolDX: DecisionDx-UM (Uveal Melanoma)
- 4Kscore Assay
- MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
- MolDX: VectraDA, a Multibiomarker Disease Activity Test for Rheumatoid Arthritis (RA)
- MolDX: Vita Risk™ Pharmacogenetic Test for Dry Agerelated Macular Degeneration (AMD)
- MolDX: Xpresys Lung
- Plastic Surgery
- Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depressive Disorder
- Visual Electrophysiology Testing
